Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 8/20 | 0.59 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.56 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.56 |
| ▸ | GNPAT | O15228 | 1/20 | 0.45 |
| ▸ | GGH | Q92820 | 1/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 2/20 | 0.43 |
| ▸ | FNTB | P49356 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12648688 | 1.00 | FOLH1 (0.59) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL468800 | 1.00 | FOLH1 (0.59) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL19185486 | 0.87 | FOLH1 (0.46) | FOLH1NAALAD2RIMKLAGNPATNOD1 | |
| SCHEMBL9074250 | 0.87 | FOLH1 (0.46) | FOLH1NAALAD2RIMKLAGNPATNOD1 | |
| SCHEMBL29822167 | 0.85 | FOLH1 (0.66) | FOLH1NAALAD2RIMKLAGNPATNOD1 | |
| SCHEMBL24302141 | 0.83 | FOLH1 (0.43) | FOLH1NAALAD2RIMKLAGNPATNOD1 | |
| SCHEMBL18272425 | 0.82 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL15958206 | 0.82 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL18082026 | 0.82 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL19718595 | 0.82 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATGGH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250228904-A1 | SYNBIOTIC COMPOSITIONS FOR METABOLIC MANAGEMENT ESPECIALLY GLUCOSE METABOLISM MANAGEMENT AND MODULATION OF SATIETY HORMONE LEVELS | EVONIK OPERATIONS GMBH (DE) | 2025-07-17 | — | — | US | disclosed |
| EP-4419121-A1 | SYNBIOTIC COMPOSITIONS FOR METABOLIC MANAGEMENT ESPECIALLY GLUCOSE METABOLISM MANAGEMENT AND MODULATION OF SATIETY HORMONE LEVELS | Evonik Operations GmbH (DE) | 2024-08-28 | — | — | EP | disclosed |
| WO-2023066533-A1 | SYNBIOTIC COMPOSITIONS FOR METABOLIC MANAGEMENT ESPECIALLY GLUCOSE METABOLISM MANAGEMENT AND MODULATION OF SATIETY HORMONE LEVELS | EVONIK OPERATIONS GMBH (DE) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023069711-A1 | FAP-TARGETED NEUTRON CAPTURE AGENTS, AND USES AND FORMULATIONS RELATED THERETO | TRUSTEES OF TUFTS COLLEGE (US) | 2023-04-27 | — | — | WO | disclosed |
| EP-2311452-B2 | Topical composition comprising n-acetyl glucosamine | YU RUEY J (US) | 2020-12-30 | — | — | EP | disclosed |
| EP-2311452-B9 | Topical composition comprising n-acetyl glucosamine | YU RUEY J (US) | 2014-12-24 | — | — | EP | disclosed |
| US-RE44302-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | YU RUEY J (US) | 2013-06-18 | — | — | US | disclosed |
| US-RE44017-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | YU RUEY J (US) | 2013-02-19 | — | — | US | disclosed |
| US-RE42902-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | TRISTRATA, INC. (US) | 2011-11-08 | — | — | US | disclosed |
| EP-2311452-A1 | Topical composition comprising n-acetyl glucosamine | Yu, Ruey J. (US) | 2011-04-20 | — | — | EP | disclosed |
| US-RE41339-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | TRISTRATA, INC. (US) | 2010-05-18 | — | — | US | disclosed |
| US-RE41278-E1 | N-acetyl aldosamines and related N-acetyl compounds, and their topical use | TRISTRATA, INC. | 2010-04-27 | — | — | US | disclosed |
| EP-2080504-A2 | Topical composition comprising n-acetylaldosamines or n-acetylamino acids | Yu, Ruey J. (US) | 2009-07-22 | — | — | EP | disclosed |
| EP-1639994-A2 | Topical composition comprising N-acetylaldosamines or N-acetylamino acids | Yu, Ruey J., Dr. (US) | 2006-03-29 | — | — | EP | disclosed |
| EP-1570840-A2 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2005-09-07 | — | — | EP | disclosed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | disclosed |
| EP-1143925-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | disclosed |
| WO-2000040217-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-07-13 | — | — | WO | disclosed |